Search
Advanced Search
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2021
New Titles 2020
Price and Ordering Information
Subscription Rates 2021
Subscription Rates 2020
eBooks Website
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Marketing Opportunities
Institutional Membership
Advertise With Us
Journals and eBooks Catalog
Media-Pack-2020
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Media Partners
Partnering Events
Promotional Services
For Authors, Editors & Librarians
Author Benefits
Author's Benefits Guide
Author Reprints
Authorship
Copyediting Services
Editorial Policies
FAQs for e-prints/reprints
Increase Visibility of your Article
General FAQs
Guidelines for Guest Editors
Journal Catalog 2020
Journal Catalog 2021
Kudos
Library Recommendations
Manuscript Transfer Facility
Online Manuscript Submission
Order Bulk ePrints
Order Bulk Reprints
Publication Cycle - Process Flowchart
Publishing Ethics
Peer Review
Self-Archiving Policies
Table of Contents Alert
Trial Requests
Webinars
Contact Us
Track Your Manuscript:
Enter Correct Manuscript Reference Number:
Submit Reference Number
Current Cancer Drug Targets
Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Impact Factor:
2.912
5 Year Impact Factor:
2.947
Subscribe to this Journal
Call for Editors
Book Proposal
Join Editorial Board
New Journal Proposal
Become a Reviewer
Become an Executive Guest Editor
Thematic Issue Proposal
Submit Abstract Online
Contents
Current Cancer Drug Targets
,
Volume 13
- Number 3
Editorial (Hot Topic: PI3K/AKT and mTOR/p70S6K1 Signaling Pathways in Human Cancer)
,
13
(
3
):
233
Bing-Hua Jiang
DOI:
10.2174/1568009611313030001
Permissions
Order Reprints
Order Eprints
Diverse Mechanisms of AKT Pathway Activation in Human Malignancy
,
13
(
3
):
234
- 244
Mitchell Cheung and Joseph R. Testa
DOI:
10.2174/1568009611313030002
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Oxygen-independent Regulation of HIF-1: Novel Involvement of PI3K/ AKT/mTOR Pathway in Cancer
,
13
(
3
):
245
- 251
Faton Agani and Bing-Hua Jiang
DOI:
10.2174/1568009611313030003
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Roles of EGFR, PI3K, AKT, and mTOR in Heavy Metal-Induced Cancer
,
13
(
3
):
252
- 266
Richard L. Carpenter and Bing-Hua Jiang
DOI:
10.2174/1568009611313030004
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Targeting the mTOR Pathway in Tumor Malignancy
,
13
(
3
):
267
- 277
Hengmiao Cheng, Marlena Walls, Sangita M. Baxi and Min-Jean Yin
DOI:
10.2174/1568009611313030005
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
IDO+ DCs and Signalling Pathways
,
13
(
3
):
278
- 288
Yue Wang, Bao-Hong Yang, Hui Li, Shui Cao, Xiu-Bao Ren and Jin-Pu Yu
DOI:
10.2174/15680096113139990073
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Novel HSP90 Inhibitor NVP-AUY922 Enhances the Anti-tumor Effect of Temsirolimus Against Oral Squamous Cell Carcinoma
,
13
(
3
):
289
- 299
Tatsuo Okui, Tsuyoshi Shimo, Takuya Fukazawa, Nur Mohammad Monsur Hassan, Tatsuki Honami, Soichiro Ibaragi, Munenori Takaoka, Yoshio Naomoto and Akira Sasaki
DOI:
10.2174/1568009611313030007
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Targeting Tyrosine Kinase Receptors in Hepatocellular Carcinoma
,
13
(
3
):
300
- 312
Jordi Muntane, Angel J. De la Rosa, Fernando Docobo, Rocio Garcia-Carbonero and Francisco J. Padillo
DOI:
10.2174/15680096113139990075
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Novel Agents, Combinations and Sequences for the Treatment of Advanced Renal Cell Carcinoma: When is the Revolution Coming?
,
13
(
3
):
313
- 325
Matteo Santoni, Mimma Rizzo, Luciano Burattini, Rossana Berardi, Giacomo Carteni and Stefano Cascinu
DOI:
10.2174/1568009611313030009
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
,
13
(
3
):
326
- 346
Ziyad Binkhathlan and Afsaneh Lavasanifar
DOI:
10.2174/15680096113139990076
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board
COPE Compliant
About the Journal
⇨ Journal Home
⇨ Editorial Policies
⇨ Editorial Board
⇨ Meet the Executive Guest Editor(s)
⇨ Board Recruitment Workflow
⇨ Join Editorial Board
⇨ Indexing Information
⇨ Announcements
⇨ Endorsements
⇨ Authors' Comments
For Authors
⇨ Author Guidelines
⇨ Animated Abstracts
⇨ Increase Visibility of your Article
⇨ Submit Abstracts Online
⇨ Submit Manuscripts Online
⇨ Open Access Funding
⇨ Publishing Ethics and Rectitude
⇨ Archiving Policies
⇨ Manuscript Transfer Facility
For Guest Editors
⇨ Thematic Issue Proposal
⇨ Forthcoming Thematic Issues
⇨ Guest Editor Guidelines
For Reviewers
⇨ Reviewer Guidelines
⇨ Peer Review Workflow
⇨ Become a Reviewer
For Librarians & Readers
⇨ Contents & Abstracts
⇨ Open Access Articles
⇨ Editor's Choice
⇨ Free Copies Online
⇨ Thematic Issues
⇨ Journal Catalog 2020
⇨ Journal Catalog 2021
⇨ Most Accessed Articles
⇨ Most Cited Articles
⇨ PURCHASE ARTICLES
⇨ Order Reprints
⇨ Subscribe
⇨ Trial Requests
⇨ Library Recommendation
Quick Links
⇨ Journal's New Website
⇨ Advertise with Us
⇨ Brand Ambassadors
⇨ Newsletter
⇨ Download PDF Flyer
⇨ Table of Contents Alert
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Advertisement
Related Journals
view more >>
Related eBooks
view more >>
eBooks Catalog
view eBooks Catalog >>
Webmaster Contact:
info@benthamscience.net
Copyright © 2021 Bentham Science
|
Privacy Policy